Our study, together with previous research, underscores the need for further investigation into the role of natriuretic peptides in IBD, particularly to determine whether timely serial measurements of NT-proBNP or proBNP could provide a clinical benefit in guiding therapy. Here, NPPB is linked to inflammatory bowel disease.